Alabama-Based Simparo Inc. Earns Fourth U.S. Patent, Backed by Innovate Alabama Investment

August 1, 2026

Simparo Inc., operating as Simparo Surgical, has received its fourth U.S. patent, U.S. Patent No. 12,661,103, which was granted on June 23, 2026. The company, based in Alabama and supported by Innovate Alabama and Hatch Fairhope, aims to enhance the state's orthopedic technology sector.

The new patent addresses challenges related to Thumb CMC reconstruction, particularly in achieving quick and secure basal joint reconstruction. Traditional methods often involve tendon harvesting and complex tensioning approaches, while Simparo's Falcon Suture Clutch uses a one-way cinching design to allow surgeons to complete repairs with controlled tension incrementally.

Chris Harber, CEO of Simparo Surgical, emphasized the company's commitment to Alabama's innovation economy, stating, "We're proud to be an Alabama company, and proud of the support that Innovate Alabama and Hatch Fairhope has placed behind our vision." He noted that this patent represents a significant achievement not only for Simparo but also for medical innovation in Alabama.

Simparo's portfolio now includes four issued patents related to its suture tensioning system, which is designed to cater to the needs of local hand surgeons and their patients. Harber expressed the company's desire to provide technological support to Alabama surgeons, reinforcing a connection between local innovation and patient care.

Innovate Alabama serves as a public-private partnership aimed at fostering small businesses and technological advancement in the state. It seeks to implement policies that promote a robust economy, while Hatch Fairhope supports startups by offering resources and networking opportunities in Baldwin County.

Simparo Inc. focuses on developing orthopedic devices and surgical methods to simplify procedures while maintaining patient stability and enhancing the overall experience.

Share
Disclaimer: This press release has been distributed on behalf of the issuing organization. PR Gun acts solely as a distribution platform and has not independently verified the accuracy, completeness, or validity of the statements contained herein.